[go: up one dir, main page]

AU1398899A - Cox-2 inhibitors in combination with centrally acting analgesics - Google Patents

Cox-2 inhibitors in combination with centrally acting analgesics

Info

Publication number
AU1398899A
AU1398899A AU13988/99A AU1398899A AU1398899A AU 1398899 A AU1398899 A AU 1398899A AU 13988/99 A AU13988/99 A AU 13988/99A AU 1398899 A AU1398899 A AU 1398899A AU 1398899 A AU1398899 A AU 1398899A
Authority
AU
Australia
Prior art keywords
cox
inhibitors
combination
centrally acting
acting analgesics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13988/99A
Inventor
Frank S Caruso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Endo Pharmaceuticals Inc
Original Assignee
Algos Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Algos Pharmaceutical Corp filed Critical Algos Pharmaceutical Corp
Publication of AU1398899A publication Critical patent/AU1398899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU13988/99A 1998-11-12 1998-11-12 Cox-2 inhibitors in combination with centrally acting analgesics Abandoned AU1398899A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/024045 WO2000029022A1 (en) 1998-11-12 1998-11-12 Cox-2 inhibitors in combination with centrally acting analgesics

Publications (1)

Publication Number Publication Date
AU1398899A true AU1398899A (en) 2000-06-05

Family

ID=22268282

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13988/99A Abandoned AU1398899A (en) 1998-11-12 1998-11-12 Cox-2 inhibitors in combination with centrally acting analgesics

Country Status (2)

Country Link
AU (1) AU1398899A (en)
WO (1) WO2000029022A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000051685A1 (en) * 1999-03-01 2000-09-08 Ortho-Mcneil Pharmaceutical, Inc. Composition comprising a tramadol material and a selective cox-2 inhibitor drug
WO2002017896A2 (en) * 2000-08-29 2002-03-07 Peter Van Patten Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid
DE10059020A1 (en) 2000-11-28 2002-05-29 Gruenenthal Gmbh Dosage forms that can be administered parenterally
WO2003040337A2 (en) * 2001-11-07 2003-05-15 Pharmacia Corporation Polyamide modulators of cox2 transcription
GB0206505D0 (en) * 2002-03-19 2002-05-01 Euro Celtique Sa Pharmaceutical combination
DK1534305T3 (en) 2003-05-07 2007-02-05 Osteologix As Treatment of cartilage / bone disorders with water-soluble strontium salts
DK1648867T3 (en) * 2003-07-17 2013-12-16 Plexxikon Inc PPAR ACTIVE CONNECTIONS
CA2919892C (en) 2013-08-12 2019-06-18 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
EP3169315B1 (en) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
EP3209282A4 (en) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI22713B (en) * 1996-04-12 2009-12-31 Searle & Co Substituted benzenesulphonamide derivatives as prodrugs of cox-2 inhibitors
TR199900298T2 (en) * 1996-08-14 1999-05-21 G.D. Searle &Co. The crystalline form of 4-(5-Methyl-3-phenylisoxazol-4-yl)BenzeneSulfonamide.
AU7472798A (en) * 1997-05-07 1998-11-27 Algos Pharmaceutical Corporation Cox-2 inhibitors in combination with nmda-blockers for treating pain
RS49982B (en) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor
FR2770131A1 (en) * 1997-10-27 1999-04-30 Union Pharma Scient Appl Analgesic combinations of a cyclooxygenase-2 inhibitor and acetaminophen or an opiate having synergistic activity

Also Published As

Publication number Publication date
WO2000029022A1 (en) 2000-05-25

Similar Documents

Publication Publication Date Title
AU1980299A (en) Embedded energy storage device
AU5872899A (en) Plug and plug set for use in wellbore
AU5343999A (en) Silicone-containing macromonomers and low water materials
AU3074001A (en) Fluorescent in situ rt-pcr
AU7472798A (en) Cox-2 inhibitors in combination with nmda-blockers for treating pain
AU2001228534A1 (en) Arrangement in connection with control device
AU1398899A (en) Cox-2 inhibitors in combination with centrally acting analgesics
AU2832399A (en) B cell inhibitors
AUPP227898A0 (en) Improvements in ultrasound techniques
AU6491699A (en) Biosensor cell device and its use
AU3150399A (en) Method and arrangement in connection with double spooling
AUPP634098A0 (en) Improvements in fluid metering technology
AU1394800A (en) Improvements in coatings
AU3086200A (en) Eyesight-correction and/or eye-training device
AU1589500A (en) Device in connection with cable unreeling
AU8812098A (en) In line filing of works
AU1676299A (en) Improvements in flocculants
AU2002313458A1 (en) Niaciamide and derivatives in combination with aminosugar
AU2002214307A1 (en) T cell line and use thereof
AU2001254976A1 (en) Electrochemical methods and cells
AU2001256680A1 (en) Hiv-producing cell line and use thereof
AU5028599A (en) Shaped concrete block with raised area and shaped concrete block kit
AUPP642798A0 (en) Improvements in water distribution
AUPP399298A0 (en) Methods of limiting the double layer effects in electrochemical systems
AU2001245405A1 (en) Polymorphisms associated with insulin-signaling and glucose-transport pathways

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase